I-131-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma

Gedik, HATİCE; Hoefnagel, Cornelis; Bais, Evert; Olmos, Renato

doi:10.1007/s00259-007-0652-6

I-131-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma

Atıf İçin Kopyala

Gedik G. K., Hoefnagel C. A., Bais E., Olmos R. A. V.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, cilt.35, sa.4, ss.725-733, 2008 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 35 Sayı: 4
Basım Tarihi: 2008
Doi Numarası: 10.1007/s00259-007-0652-6
Dergi Adı: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.725-733
Hacettepe Üniversitesi Adresli: Evet

Özet

Purpose (131)Iodine metaiodobenzylguanidine (I-131-MIBG) is a radiopharmaceutical used for scintigraphic localisation of phaeochromocytomas and paragangliomas. The experience with its therapeutic use is limited. We report our experience for the treatment of malignant phaeochromocytoma and paraganglioma.